loadpatents
name:-0.021233081817627
name:-0.012918949127197
name:-0.0012061595916748
Mauger; Jacques Patent Filings

Mauger; Jacques

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mauger; Jacques.The latest application filed is for "bcat modulation".

Company Profile
0.15.20
  • Mauger; Jacques - Durham NC
  • Mauger; Jacques - Bridgewater NJ
  • Mauger; Jacques - Oro Valley AZ
  • Mauger; Jacques - Tucson AZ
  • Mauger; Jacques - Tuscon AZ
  • Mauger; Jacques - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bcat Modulation
App 20220274967 - August; Paul R. ;   et al.
2022-09-01
Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
Grant 10,138,235 - Alcouffe , et al. Nov
2018-11-27
Compositions and methods for analyzing histidine phosphorylation
Grant 9,957,294 - Stankova , et al. May 1, 2
2018-05-01
Generation and use of polyclonal and monoclonal antibodies specific for 3-phosphohistidine
Grant 9,850,319 - Hunter , et al. December 26, 2
2017-12-26
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
App 20170231998 - ALCOUFFE; Chantal ;   et al.
2017-08-17
Generation And Use Of Polyclonal And Monoclonal Antibodies Specific For 3-phosphohistidine
App 20170210824 - Hunter; Tony ;   et al.
2017-07-27
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
App 20170174681 - ALCOUFFE; Chantal ;   et al.
2017-06-22
Compositions And Methods For Analyzing Histidine Phosphorylation
App 20150065395 - Stankova; Magda ;   et al.
2015-03-05
Compositions And Methods For Analyzing Histidine Phosphorylation
App 20150004173 - Stankova; Magda ;   et al.
2015-01-01
Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
App 20140350006 - Alcouffe; Chantal ;   et al.
2014-11-27
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
Grant 8,791,133 - Schoenafinager , et al. July 29, 2
2014-07-29
Substituted pyrazoles, compositions containing these, method of production and use
Grant 8,420,824 - Bjergarde , et al. April 16, 2
2013-04-16
Substituted pyrazoles, compositions containing these, method of production and use
Grant 8,410,286 - Bjergarde , et al. April 2, 2
2013-04-02
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
App 20130040981 - SCHOENAFINAGER; Karl ;   et al.
2013-02-14
1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
Grant 8,163,768 - Mauger , et al. April 24, 2
2012-04-24
Substituted Pyrazoles, Compositions Containing These, Method Of Production And Use
App 20110237641 - BJERGARDE; Kirsten ;   et al.
2011-09-29
Substituted Pyrazoles, Compositions Containing These, Method Of Production And Use
App 20110237801 - BJERGARDE; Kirsten ;   et al.
2011-09-29
Substituted pyrazoles, compositions containing these, method of production and use
Grant 7,989,439 - Bjergarde , et al. August 2, 2
2011-08-02
Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,825,115 - Patek , et al. November 2, 2
2010-11-02
Substituted Pyrazoles, Compositions Containing These, Method Of Production And Use
App 20090291984 - Bjergarde; Kirsten ;   et al.
2009-11-26
1,4-Dihydropyridine-Fused Heterocycles, Process for Preparing the Same, Use and Compositions Containing Them
App 20080261969 - MAUGER; Jacques ;   et al.
2008-10-23
Cyclic Urea Compounds, Preparation Thereof and Pharmaceutical Use Thereof as Kinase Inhibitors
App 20080108654 - PATEK; Marcel ;   et al.
2008-05-08
Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
Grant 7,354,933 - Patek , et al. April 8, 2
2008-04-08
Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors
App 20080021029 - Strobel; Hartmut ;   et al.
2008-01-24
Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
Grant 7,279,480 - Bhatnagar , et al. October 9, 2
2007-10-09
Pyridazine derivative, pharmaceutical composition thereof, its pharmaceutical use, and process for its preparation
Grant 7,223,758 - Bhatnagar , et al. May 29, 2
2007-05-29
Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation
Grant 7,034,022 - Bhatnagar , et al. April 25, 2
2006-04-25
Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
App 20050215553 - Bhatnagar, Neerja ;   et al.
2005-09-29
Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation
App 20050171346 - Bhatnagar, Neerja ;   et al.
2005-08-04
Pyridazine derivative, pharmaceutical composition thereof, its pharmaceutical use, and process for its preparation
App 20050165017 - Bhatnagar, Neerja ;   et al.
2005-07-28
Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
App 20040248884 - Patek, Marcel ;   et al.
2004-12-09
Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
App 20030100550 - Bhatnagar, Neerja ;   et al.
2003-05-29
New 17-halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them
App 20030022874 - Bouali, Yasmina ;   et al.
2003-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed